XMax Inc. completed a transaction on August 10, 2026, purchasing 561,426 ordinary shares of Aerora Technology Co., Ltd. for an aggregate price of US$12,003,287.95, approximately $21.38 per share. The acquisition was executed via a Securities Purchase Agreement with Cobalt Pacific Holdings Ltd. and Aerora Technology Co., Ltd. Additionally, the company's subsidiary contributed to a private investment fund targeting Figure AI Inc. XMax Inc. operates in the technology sector.

XMax Inc. held a special stockholder meeting on July 24, 2026, where shareholders approved two equity issuances exceeding 20% of outstanding shares at prices below Nasdaq's Minimum Price threshold. Proposal 1 authorized a private placement offering, receiving 25,775,447 votes in favor. Proposal 2 authorized a registered direct offering under Form S-3 (Registration Number 333-295406), receiving 25,775,415 votes in favor. Proposal 3 granted the Chairman discretionary authority to adjourn the meeting to solicit additional proxies, receiving 25,775,196 votes in favor. The company operates in the technology sector, providing digital solutions and services.

Xmax Beta Holdings Ltd., a subsidiary of XMax Inc., invested an aggregate amount of $8,320,000 to increase its interest in Preamble X Capital I to over 99.9%. Subsequently, Preamble X Capital I completed a $8,000,000 transaction to subscribe for approximately 48% interests in a private investment fund that intends to invest in Figure AI Inc. XMax Inc. operates in the investment and holding company sector.

Xmax Beta Holdings Ltd., a subsidiary of XMax Inc., entered into a Subscription Agreement with Preamble X Capital I to increase its interest in the entity to more than 99.9% via an aggregate subscription of US$8,770,000 on July 6, 2026. The subscription was completed on July 7, 2026. XMax Inc. operates in the technology and investment management sector.

On July 1, 2026, XMax Inc. entered into Securities Purchase Agreements for a private placement of 434,600 shares of common stock to non-U.S. investors. The shares were sold at a price of $8.454 per share, resulting in total aggregate proceeds of $3,674,108.40. The purchasers are subject to an 18-month lock-up period prohibiting the sale or transfer of the shares without company consent. The transaction was completed under Regulation S. XMax Inc. operates in the healthcare industry, providing medical device and equipment solutions.